ALPS

CAS No. 82611-85-6

ALPS( N-Ethyl-N-sulfopropylaniline sodium salt )

Catalog No. M24816 CAS No. 82611-85-6

ALPS (N-Ethyl-N-sulfopropylaniline sodium salt) is a bio-chemical reagents/chromogenic reagent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
50MG 27 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALPS
  • Note
    Research use only, not for human use.
  • Brief Description
    ALPS (N-Ethyl-N-sulfopropylaniline sodium salt) is a bio-chemical reagents/chromogenic reagent.
  • Description
    ALPS (N-Ethyl-N-sulfopropylaniline sodium salt) is a bio-chemical reagents/chromogenic reagent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-Ethyl-N-sulfopropylaniline sodium salt
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82611-85-6
  • Formula Weight
    265.3
  • Molecular Formula
    C11H16NNaO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (942.33 mM)
  • SMILES
    O=S(CCCN(CC)C1=CC=CC=C1)([O-])=O.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Poricoic acid AM

    Poricoic acid AM is a triterpenoid compound extracted from Poria cocos, demonstrating anti-tumor activity.

  • N-trans-caffeoylocto...

    N-trans-Caffeoyltyramine has both arginase inhibitory property and antioxidant capacity.

  • RMC-6291

    RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .